Free Trial

Ambev (ABEV) Stock Forecast & Price Target

Ambev logo
$2.41 +0.05 (+2.12%)
As of 03:58 PM Eastern

Ambev - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
1
Hold
4
Buy
0

Based on 5 Wall Street analysts who have issued ratings for Ambev in the last 12 months, the stock has a consensus rating of "Reduce." Out of the 5 analysts, 1 has given a sell rating, and 4 have given a hold rating for ABEV.

Consensus Price Target

$2.60
7.88% Upside
According to the 5 analysts' twelve-month price targets for Ambev, the average price target is $2.60. The highest price target for ABEV is $2.70, while the lowest price target for ABEV is $2.50. The average price target represents a forecasted upside of 7.88% from the current price of $2.41.
Get the Latest News and Ratings for ABEV and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Ambev and its competitors.

Sign Up

ABEV Analyst Ratings Over Time

TypeCurrent Forecast
6/30/24 to 6/30/25
1 Month Ago
5/31/24 to 5/31/25
3 Months Ago
4/1/24 to 4/1/25
1 Year Ago
7/1/23 to 6/30/24
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
0 Buy rating(s)
0 Buy rating(s)
1 Buy rating(s)
2 Buy rating(s)
Hold
4 Hold rating(s)
4 Hold rating(s)
3 Hold rating(s)
4 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$2.60$2.70$2.45$2.68
Forecasted Upside7.88% Upside10.66% Upside4.48% Upside30.73% Upside
Consensus Rating
Reduce
Reduce
Hold
Hold

ABEV Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

ABEV Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Ambev Stock vs. The Competition

TypeAmbevConsumer Staples CompaniesS&P 500
Consensus Rating Score
1.80
2.54
2.53
Consensus RatingReduceModerate BuyModerate Buy
Predicted Upside7.88% Upside64.64% Upside12.55% Upside
News Sentiment Rating
Positive News

See Recent ABEV News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
6/4/2025UBS Group
3 of 5 stars
R. Alcantara
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetNeutral ➝ Neutral$2.60 ➝ $2.70+8.65%
5/12/2025Barclays
3 of 5 stars
Benjamin Theurer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetEqual Weight ➝ Equal Weight$2.00 ➝ $2.50+0.20%
4/7/2025Morgan Stanley
3 of 5 stars
 DowngradeEqual Weight ➝ Underweight
1/22/2025Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Renata Cabral
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Neutral
1/17/2025Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Neutral
3/1/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOverweight ➝ Neutral
11/22/2023Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageHold$2.86+4.57%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 05:35 PM ET.


Should I Buy Ambev Stock? ABEV Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Saturday, June 28, 2025. Please send any questions or comments about these Ambev pros and cons to contact@marketbeat.com.

Ambev
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Ambev S.A.:

  • The current stock price is around $2.47, which is relatively stable compared to its fifty-two week high of $2.64, indicating potential for growth.
  • Ambev S.A. has a strong market capitalization of approximately $38.92 billion, suggesting a solid position in the market and potential for long-term stability.
  • The company reported a net margin of 15.76%, which reflects efficient management and profitability, making it an attractive option for investors seeking returns.
  • Recent analyst upgrades, including a target price increase from UBS Group, indicate positive sentiment and potential for stock appreciation.
  • Ambev S.A. has a diverse product portfolio, including beer and non-alcoholic beverages, which can help mitigate risks associated with market fluctuations.

Ambev
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Ambev S.A. for these reasons:

  • Millennium Management LLC significantly reduced its stake in Ambev S.A. by 67.8%, which may signal a lack of confidence among institutional investors.
  • One equities research analyst has rated the stock with a sell rating, indicating potential concerns about the company's future performance.
  • The company has a relatively high price-to-earnings (P/E) ratio of 13.72, which could suggest that the stock is overvalued compared to its earnings.
  • Ambev S.A. has recently cut its dividend, which may be a red flag for income-focused investors looking for consistent returns.
  • Market volatility and economic uncertainties could impact consumer spending on beverages, affecting Ambev's sales and profitability.

ABEV Forecast - Frequently Asked Questions

According to the research reports of 5 Wall Street equities research analysts, the average twelve-month stock price forecast for Ambev is $2.60, with a high forecast of $2.70 and a low forecast of $2.50.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Ambev in the last year. There is currently 1 sell rating and 4 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "reduce" ABEV shares.

According to analysts, Ambev's stock has a predicted upside of 7.88% based on their 12-month stock forecasts.

Over the previous 90 days, Ambev's stock had 2 downgrades by analysts.

Ambev has been rated by research analysts at Barclays, Morgan Stanley, and UBS Group in the past 90 days.

Analysts like Ambev less than other "consumer staples" companies. The consensus rating for Ambev is Reduce while the average consensus rating for "consumer staples" companies is Moderate Buy. Learn more on how ABEV compares to other companies.


This page (NYSE:ABEV) was last updated on 6/30/2025 by MarketBeat.com Staff
From Our Partners